TNF-α and IL-6: The Link between Immune and Bone System

被引:301
作者
Wang, Tiantian [1 ,2 ]
He, Chengqi [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Rehabil Med, 37 Guoxue Xiang, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Key Lab Rehabil Med, Chengdu 610041, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
TNF-alpha; IL-6; osteoimmunology; osteoclast; osteoblast; osteocyte; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; MESENCHYMAL STEM-CELLS; NATURAL-KILLER-CELLS; RHEUMATOID-ARTHRITIS PATIENTS; LEUKEMIA INHIBITORY FACTOR; HUMAN OSTEOCLAST FORMATION; COLONY-STIMULATING FACTOR; T-CELLS; OSTEOBLAST DIFFERENTIATION;
D O I
10.2174/1389450120666190821161259
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Osteoimmunology is a new subject which focuses on the communication between the immune and the skeletal systems. Both the immune system and bone communicate with each other. Pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) play important roles in immune responses and bone metabolism. TNF-alpha and IL-6 enhance macrophage activation and antigen presentation, as well as regulating immunity through different mechanisms. A variety of groups have reported that TNF-alpha suppresses osteoblasts activity at some stages of differentiation and stimulates osteoclast proliferation and differentiation. In contrast, IL-6 mediates the actions of osteoblasts and osteoclasts through sophisticated mechanisms, which reflect dual effects. Both TNF-alpha and IL-6 can mediate the activity of osteocytes. Furthermore, both TNF-alpha and IL-6 are important pathogenic factors related to immune-mediated bone diseases including rheumatoid arthritis and postmenopausal osteoporosis. This review will discuss the contradictory findings concerning TNF-alpha and IL-6 in osteoimmunology and their potential for clinical application.
引用
收藏
页码:213 / 227
页数:15
相关论文
共 196 条
[1]   Tumor necrosis factor-α inhibits pre-osteoblast differentiation through its type-1 receptor [J].
Abbas, S ;
Zhang, YH ;
Clohisy, JC ;
Abu-Amer, Y .
CYTOKINE, 2003, 22 (1-2) :33-41
[2]   Immune regulation of bone loss by Th17 cells [J].
Adamopoulos, Iannis E. ;
Bowman, Edward P. .
ARTHRITIS RESEARCH & THERAPY, 2008, 10 (05)
[3]   Chemokines and tuberculosis [J].
Algood, HMS ;
Chan, J ;
Flynn, JL .
CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (06) :467-477
[4]  
Amarasekara DS, 2018, IMMUNE NETW, V18
[5]   Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency [J].
Ammann, P ;
Rizzoli, R ;
Bonjour, JP ;
Bourrin, S ;
Meyer, JM ;
Vassalli, P ;
Garcia, I .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1699-1703
[6]  
Angelotti F, 2017, CLIN EXP RHEUMATOL, V35, P368
[7]   Regulation of hematopoietic stem cells by bone marrow stromal cells [J].
Anthony, Bryan A. ;
Link, Daniel C. .
TRENDS IN IMMUNOLOGY, 2014, 35 (01) :32-37
[8]   Osteoimmunology - Bone versus immune system [J].
Arron, JR ;
Choi, Y .
NATURE, 2000, 408 (6812) :535-536
[9]   Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts [J].
Azuma, Y ;
Kaji, K ;
Katogi, R ;
Takeshita, S ;
Kudo, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (07) :4858-4864
[10]   IL-6 Alters Osteocyte Signaling toward Osteoblasts but Not Osteoclasts [J].
Bakker, A. D. ;
Kulkarni, R. N. ;
Klein-Nulend, J. ;
Lems, W. F. .
JOURNAL OF DENTAL RESEARCH, 2014, 93 (04) :394-399